$SUNPHARMA is in focus after announcing a ₹271 crore acquisition of Innovcare, a move aimed at expanding its product portfolio. The acquisition is expected to create synergies, widen market reach and support long-term growth. Investors will closely watch how effectively the company integrates Innovcare and translates the deal into higher revenues and profitability. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.